Science
New European database to support environmental risk assessment of human pharmaceuticals
Source: Phys.org · Published
The PREMIER project, a public-private European consortium of research organizations (like Radboud University) and international pharmaceutical companies, has launched a new database to support the environmental risk assessment (ERA) of human pharmaceuticals. The data is publicly accessible, free of charge. The database was built with key user requirements in mind.
Key points
- The PREMIER project, a public-private European consortium of research organizations (like Radboud University) and international pharmaceutical companies, has launched a new database to support the environmental risk assessment (ERA) of human pharmaceuticals.
- The data is publicly accessible, free of charge.
- The database was built with key user requirements in mind.
Related stories
- Researchers explore how AI could improve earthquake safety
Phys.org · 5 Nov 2026, 18:20
- A well-timed blink helps us to look around
Phys.org · 5 Nov 2026, 18:10
- Coating made from renewable plant-based materials could simplify recycling while reducing exposure to microplastics
Phys.org · 5 Nov 2026, 18:00
- A sweeter future? AI helps scientists discover new sugar substitutes
Phys.org · 5 Nov 2026, 17:40
- After 40 years of searching, physicists find evidence for an ultrarare particle decay
Phys.org · 5 Nov 2026, 17:30
- Study suggests there is no 'right' way to teach statistics, giving flexibility to educators
Phys.org · 5 Nov 2026, 17:20
We are a news aggregator: we show the headline and a short excerpt with a link to the original source. We never republish full articles.